All OTC Ingredient TEAs Get Review Deadlines In Senate Draft Bill
This article was originally published in The Tan Sheet
Executive Summary
Senate HELP Committee leaders release a draft bill that expands on changes proposed in the House’s Sunscreen Innovation Act by requiring deadlines for FDA review of all OTC ingredient TEAs. In a draft bill, Chairman Tom Harkin and other HELP members propose setting “reasonable” deadlines for TEA reviews.